Log in
|
Specification |
Details |
|
Drug Detected |
Dextromethorphan (DXM) |
|
Cutoff Level |
20 ng/mL |
|
Sample Type |
Human Urine |
|
Test Format |
Rapid Test Strip |
|
Time to Results |
Approximately 5 Minutes |
|
Intended Use |
Professional & Forensic Use Only |
Using the test is simple and requires only a few steps:
Remove the test strip from the sealed pouch and use it promptly.
Hold the strip by the labeled end only and avoid touching the test membrane.
Dip the test strip vertically into the urine specimen for 10–15 seconds, without immersing beyond the MAX line.
Remove the strip and place it on a clean, dry, non-absorbent surface.
Allow the test to develop and read the results within 3–5 minutes. Do not interpret results after 10 minutes.
Always follow the testing instructions carefully to ensure accurate specimen collection and proper result interpretation
Dextromethorphan (DXM) is a widely used over-the-counter (OTC) cough suppressant found in many cold and cough medications. When taken at the recommended therapeutic dose, DXM helps suppress coughing by acting on the cough center in the brain. However, when consumed in excessive amounts, DXM can produce psychoactive and dissociative effects, making it a substance that may be misused or abused.
Because of its potential for recreational misuse, DXM screening has become increasingly important in clinical, workplace, rehabilitation, and forensic drug testing programs
Dextromethorphan is commonly used to relieve temporary coughing associated with:
Common cold
Influenza (Flu)
Upper respiratory infections
Seasonal allergies
Other minor respiratory illnesses
It is available in a variety of formulations, including syrups, capsules, tablets, lozenges, and liquid gels
Although DXM is considered safe when used according to the manufacturer's instructions, consuming large quantities may lead to intoxication and serious health risks.
High-dose DXM misuse can affect the central nervous system and may cause hallucinations, impaired judgment, and dissociative experiences. Because many DXM-containing products are easily available without a prescription, misuse is most commonly associated with recreational use.
Rapid screening helps identify possible DXM misuse in professional testing environments.
The effects of excessive DXM consumption may include:
Euphoria
Dizziness
Drowsiness
Confusion
Hallucinations
Impaired coordination
Blurred vision
Slurred speech
Increased heart rate
Nausea
Severe misuse may lead to agitation, seizures, loss of consciousness, respiratory depression, and other serious complications
Dextromethorphan is commonly known by several street names, including:
DXM
Robo
Skittles
Triple C
Dex
Robo-Tripping
Poor Man's PCP
The Dextromethorphan Rapid Drug Test provides several advantages for professional drug screening:
Rapid results in approximately 5 minutes
High sensitivity with a 20 ng/mL cutoff
Up to 99% accuracy
Simple dip-and-read procedure
No specialized laboratory equipment required
Easy interpretation of results
Reliable preliminary screening
Suitable for clinical, workplace, rehabilitation, and forensic testing
Convenient for routine and high-volume screening programs
For best performance:
Store the test according to the recommended storage temperature.
Keep the test strip in its sealed pouch until ready for use.
Use the test immediately after opening the pouch.
Do not use the product after the expiration date.
Avoid exposure to excessive heat, moisture, or direct sunlight.
Handle urine specimens using appropriate laboratory safety procedures
The Dextromethorphan Rapid Drug Test is intended to provide preliminary qualitative screening results only.
A positive result indicates the possible presence of DXM above the screening cutoff but does not determine the amount consumed or the degree of impairment.
A negative result does not necessarily exclude DXM use if the drug concentration is below the cutoff level or outside the detection window.
Certain factors, including specimen quality and testing procedures, may affect test performance.
All preliminary positive results should be confirmed using GC-MS or LC-MS/MS before medical, legal, employment, or administrative decisions are made
The test is designed to detect Dextromethorphan (DXM) in human urine using a 20 ng/mL cutoff level.
Results are available in approximately 5 minutes when the test is performed according to the instructions.
No. This product is intended for professional and forensic screening only and is not intended for medical diagnosis.
No. This is a screening test. Any preliminary positive result should be confirmed using GC-MS or LC-MS/MS.
The test is intended for clinical laboratories, workplace drug testing programs, occupational health providers, forensic laboratories, law enforcement agencies, rehabilitation centers, and other professional drug screening environments.
The Dextromethorphan (DXM) Rapid Drug Test provides a fast, accurate, and easy-to-use solution for the preliminary detection of Dextromethorphan (DXM) in human urine. Featuring a 20 ng/mL cutoff level, simple test strip format, and results in approximately 5 minutes, it is an efficient choice for routine professional drug screening.
Suitable for clinical, workplace, rehabilitation, occupational health, and forensic testing environments, the test delivers reliable preliminary results without the need for specialized laboratory equipment. Its straightforward procedure and high level of accuracy make it an effective option for both routine and high-volume screening programs.
As with all rapid immunoassay drug screening devices, any preliminary positive result should be confirmed using Gas Chromatography–Mass Spectrometry (GC-MS) or Liquid Chromatography–Tandem Mass Spectrometry (LC-MS/MS) before medical, legal, employment, or administrative decisions are made. The Dextromethorphan (DXM) Rapid Drug Test is intended for professional and forensic use only and is not intended for medical diagnosis or home testing.
The Dextromethorphan (DXM) Rapid Drug Test is a single-panel urine screening device designed for the rapid qualitative detection of Dextromethorphan (DXM) in human urine. Using an easy-to-use test strip format, the device delivers preliminary results in as little as 5 minutes, making it an efficient solution for professional drug screening.
Designed with a 20 ng/mL cutoff level, the DXM Rapid Drug Test provides reliable screening for the misuse of dextromethorphan, a common cough suppressant ingredient found in many over-the-counter cold and cough medications. When taken in excessive amounts, DXM can produce psychoactive effects and is therefore included in specialized drug screening programs.
The test requires only a urine specimen and a simple dip-and-read procedure. No specialized equipment or laboratory instruments are needed, making it suitable for routine screening in clinical, workplace, and forensic environments.
With up to 99% accuracy, the Dextromethorphan Rapid Drug Test offers dependable preliminary screening while supporting fast decision-making in professional testing programs. Any preliminary positive result should be confirmed using an appropriate laboratory confirmation method such as Gas Chromatography–Mass Spectrometry (GC-MS) or Liquid Chromatography–Tandem Mass Spectrometry (LC-MS/MS).
The test is intended for forensic and professional use only and is not intended for medical diagnosis or home use
Dextromethorphan (DXM)
DXM is generally detectable in urine for approximately 1–3 days after use. Detection time may vary depending on the amount consumed, frequency of use, metabolism, age, hydration, and overall health
This Dextromethorphan Rapid Drug Test uses a screening cutoff of:
Dextromethorphan (DXM): 20 ng/mL
Samples at or above this concentration may produce a preliminary positive result and should be confirmed using an appropriate laboratory confirmation method
A colored line appears in both the Control (C) and Test (T) regions. Even if the Test (T) line is faint, the result should be interpreted as negative, indicating that the concentration of Dextromethorphan (DXM) is below the 20 ng/mL cutoff level
A colored line appears only in the Control (C) region, while no line appears in the Test (T) region. This indicates that the concentration of DXM may be at or above the 20 ng/mL screening cutoff.
Because this device provides preliminary screening results only, all positive results should be confirmed using a more specific laboratory method such as Gas Chromatography–Mass Spectrometry (GC-MS) or Liquid Chromatography–Tandem Mass Spectrometry (LC-MS/MS)
If the Control (C) line does not appear, the test is invalid, regardless of whether a Test line is visible. An invalid result may occur due to insufficient specimen volume, improper testing technique, or a defective device.
Dextromethorphan (DXM) Rapid Drug Test | Serenity SM-DOA-DXM 25/Box
Sign up for updates from leading retailers
